AR073365A1 - Preparacion farmaceutica solida de liberacion sostenida - Google Patents

Preparacion farmaceutica solida de liberacion sostenida

Info

Publication number
AR073365A1
AR073365A1 ARP090103419A ARP090103419A AR073365A1 AR 073365 A1 AR073365 A1 AR 073365A1 AR P090103419 A ARP090103419 A AR P090103419A AR P090103419 A ARP090103419 A AR P090103419A AR 073365 A1 AR073365 A1 AR 073365A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical preparation
solid pharmaceutical
sugar
preparation according
alcohol
Prior art date
Application number
ARP090103419A
Other languages
English (en)
Inventor
Kai Suzuki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR073365A1 publication Critical patent/AR073365A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicacion 1: Una preparacion farmacéutica solida tipo matriz que comprende: (a) una sustancia farmacologicamente activa; (b) calcio policarbofilo; y (c) un azucar y)o un azucar alcohol, siendo (c) azucar y/o azucar alcohol por lo menos un miembro seleccionado del grupo consistente de trehalosa, lactitol, maltosa, maltitol, sacarosa, sorbitol, xilitol, erithritol, manitol, lactosa, e isomaltooligosacárido. Reivindicacion 4: La preparacion farmacéutica solida de acuerdo con la reivindicacion 1, que comprende adicionalmente (d) partículas finas insolubles en agua. Reivindicacion 7: La preparacion farmacéutica solida de acuerdo con la reivindicacion 4, que comprende adicionalmente (e) un desintegrante tipo mecha. Reivindicacion 8: La preparacion farmacéutica solida de acuerdo con la reivindicacion 7, donde el (e) desintegrante tipo mecha es carmelosa. Reivindicacion 9: La preparacion farmacéutica solida de acuerdo con la reivindicacion 4, donde las (d) partículas finas insolubles en agua son por lo menos un miembro seleccionado de grupo consistente de dioxido de silicio coloidal, dioxido de silicio hidratado, ácido silícico anhídrido ligero, talco, oxido de titanio, estearato de magnesio y etil celulosa. Reivindicacion 14: La preparacion farmacéutica solida de acuerdo con la reivindicacion 1, donde el (c) azucar y/o azucar de alcohol es por lo menos un miembro seleccionado del grupo consistente de monohidrato de maltosa, maltitol, monohidrato de lactitol, y dihidrato de trehalosa.
ARP090103419A 2008-09-05 2009-09-04 Preparacion farmaceutica solida de liberacion sostenida AR073365A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008228569 2008-09-05

Publications (1)

Publication Number Publication Date
AR073365A1 true AR073365A1 (es) 2010-11-03

Family

ID=41226333

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103419A AR073365A1 (es) 2008-09-05 2009-09-04 Preparacion farmaceutica solida de liberacion sostenida

Country Status (9)

Country Link
US (1) US9173844B2 (es)
EP (1) EP2328560A1 (es)
JP (2) JP5745399B2 (es)
KR (1) KR20110052731A (es)
CN (1) CN102143738A (es)
AR (1) AR073365A1 (es)
CA (1) CA2736024A1 (es)
TW (1) TW201010743A (es)
WO (1) WO2010026971A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101919864A (zh) * 2010-06-21 2010-12-22 天津市汉康医药生物技术有限公司 托伐普坦药物组合物及其制备方法
CN102552278A (zh) * 2010-12-23 2012-07-11 天津泰普药品科技发展有限公司 一种提高难溶性药物托伐普坦溶出度的药物组合物
JP5677630B2 (ja) 2012-07-20 2015-02-25 大塚製薬株式会社 表面にインクの乾燥皮膜を有する錠剤、及びインクジェットプリンタ用インク
TWI615157B (zh) 2013-02-06 2018-02-21 大塚製藥股份有限公司 包括不定形西洛他唑的固體分散劑
TWI660748B (zh) 2013-03-01 2019-06-01 日商大塚製藥股份有限公司 用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液
JP7161176B2 (ja) * 2017-07-11 2022-10-26 トーアエイヨー株式会社 口腔内崩壊錠及びその製造方法
CN111888335A (zh) * 2020-08-21 2020-11-06 福安药业集团重庆礼邦药物开发有限公司 一种托伐普坦的药物固体制剂及制备方法
WO2023128905A1 (en) * 2021-12-30 2023-07-06 Santa Farma Ilac Sanayii A.S. Pharmaceutical composition comprising amorphous tolvaptan
WO2023158411A1 (en) * 2022-02-18 2023-08-24 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A tablet of tolvaptan and at least one binder processed with wet granulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273209B1 (en) 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
EP0497956B1 (en) * 1990-08-21 1996-05-01 TheraTech, Inc. Controlled release formulations
DE4036757A1 (de) * 1990-11-17 1992-05-21 Bayer Ag Antazida-zubereitung mit verlaengerter magenverweilzeit
JP2609022B2 (ja) 1990-11-29 1997-05-14 北陸製薬株式会社 ポリカルボフィルカルシウム含有製剤
JPH07126163A (ja) 1993-10-08 1995-05-16 Theratech Inc 制御放出性ピロカルピン送達システム
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
WO2003013609A1 (en) * 2001-08-03 2003-02-20 Takeda Chemical Industries, Ltd. Sustained-release medicines
WO2003031442A1 (fr) * 2001-10-05 2003-04-17 Takeda Chemical Industries, Ltd. Composes heterocycliques, derives oxazole, procede permettant de les presenter et leur utilisation
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
WO2005007105A2 (en) * 2003-07-10 2005-01-27 Smithkline Beecham Corporation Pharmaceutical compositions
JP4567640B2 (ja) * 2005-07-29 2010-10-20 田辺三菱製薬株式会社 小型化塩酸サルポグレラート経口投与製剤

Also Published As

Publication number Publication date
KR20110052731A (ko) 2011-05-18
JP5745399B2 (ja) 2015-07-08
WO2010026971A1 (en) 2010-03-11
JP2012501960A (ja) 2012-01-26
US9173844B2 (en) 2015-11-03
JP2015061887A (ja) 2015-04-02
TW201010743A (en) 2010-03-16
US20110165249A1 (en) 2011-07-07
EP2328560A1 (en) 2011-06-08
CN102143738A (zh) 2011-08-03
CA2736024A1 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
AR073365A1 (es) Preparacion farmaceutica solida de liberacion sostenida
ES2565464T3 (es) Pastilla medicamentosa con liberación lenta del principio activo
ES2262999T3 (es) Composicion farmaceutica orodispersable de agomelatina.
NZ598993A (en) Multi-portion intra-oral dosage form with organoleptic properties
ES2694224T3 (es) Comprimido de desintegración oral y procedimiento para producir el mismo
AR069128A1 (es) Forma de dosificacion que se desintegra oralmente y proceso de preparacion
PE20090185A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
JP6073543B2 (ja) ロラタジン含有口腔内崩壊錠の製造方法
JP2007197357A5 (es)
WO2011048563A2 (en) Orally disintegrating tablets of betahistine
RU2014137096A (ru) Перорально вводимая фармацевтическая композиция
KR20190087569A (ko) 카바메이트 화합물을 포함하는 구강 붕해 정제
EA201170695A1 (ru) Улучшенная стабильность таблеток карбоната кальция при растворении
US20090062404A1 (en) Pharmaceutical composition
RU2005105945A (ru) Таблетки фозиноприла натрия, устойчивые при хранении
KR20100086140A (ko) 몬테루카스트를 활성성분으로 함유하는 구강 내 속붕해정 조성물 및 그 제조방법
AR070530A1 (es) Comprimido de desintegracion oral
ES2268372T3 (es) Composicion farmaceutica de perindopril bucodispersable.
JPWO2006046527A1 (ja) 口腔内溶解用固形製剤
US20150025112A1 (en) Orally disintegrating tablet formulations of donepezil
US20160136091A1 (en) Orally Disintegrating Tablet
WO2019151964A2 (en) Orally disintegrating formulations of saxagliptin
JP2011173848A (ja) 口腔内速崩壊錠
ES2314440T3 (es) Composicion farmaceutica bucodispersable de un compuesto antitrombotico.
EP2403485A2 (en) Pharmaceutical composition containing rasagiline mesylate

Legal Events

Date Code Title Description
FB Suspension of granting procedure